Transfer of cGAMP into bystander cells via LRRC8 volume-regulated anion channels augments STING-mediated interferon responses and anti-viral immunity
Authors
- C. Zhou
- X. Chen
- R. Planells-Cases
- J. Chu
- L. Wang
- L. Cao
- Z. Li
- K.I. López-Cayuqueo
- Y. Xie
- S. Ye
- X. Wang
- F. Ullrich
- S. Ma
- Y. Fang
- X. Zhang
- Z. Qian
- X. Liang
- S.Q. Cai
- Z. Jiang
- D. Zhou
- Q. Leng
- T.S. Xiao
- K. Lan
- Ji. Yang
- H. Li
- C. Peng
- Z. Qiu
- T.J. Jentsch
- H. Xiao
Journal
- Immunity
Citation
- Immunity 52 (5): 767-781
Abstract
The enzyme cyclic GMP-AMP synthase (cGAS) senses cytosolic DNA in infected and malignant cells and catalyzes the formation of 2'3'cGMP-AMP (cGAMP), which in turn triggers interferon (IFN) production via the STING pathway. Here, we examined the contribution of anion channels to cGAMP transfer and anti-viral defense. A candidate screen revealed that inhibition of volume-regulated anion channels (VRACs) increased propagation of the DNA virus HSV-1 but not the RNA virus VSV. Chemical blockade or genetic ablation of LRRC8A/SWELL1, a VRAC subunit, resulted in defective IFN responses to HSV-1. Biochemical and electrophysiological analyses revealed that LRRC8A/LRRC8E-containing VRACs transport cGAMP and cyclic dinucleotides across the plasma membrane. Enhancing VRAC activity by hypotonic cell swelling, cisplatin, GTPγS, or the cytokines TNF or interleukin-1 increased STING-dependent IFN response to extracellular but not intracellular cGAMP. Lrrc8e(-/-) mice exhibited impaired IFN responses and compromised immunity to HSV-1. Our findings suggest that cell-to-cell transmission of cGAMP via LRRC8/VRAC channels is central to effective anti-viral immunity.